Clearline Capital’s Opko Health OPK Stock Holding History

Clearline Capital’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-726,582	Closed	-$1.08M	–	140
2024 Q3	$1.08M	Buy	+726,582	New	+$1.08M	0.05%	112

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Clearline Capital's OPK Position: Q4 2024 in Review

Clearline Capital sold out of Opko Health (OPK) in Q4 2024, closing a stake of 726,582 shares — an estimated $1.08M sold.

Clearline Capital first reported a position in OPK in Q3 2024 and held it in 1 quarter. The position peaked at $1.08M in Q3 2024. 235 funds tracked by Wall St. Rank hold OPK as of Q4 2024.

Clearline Capital reported no remaining Opko Health position as of Q4 2024 after selling out during the quarter.
Clearline Capital sold 726,582 Opko Health shares in Q4 2024, an estimated $1.08M.
Clearline Capital first reported a position in Opko Health in Q3 2024 and held it in 1 quarter.
Clearline Capital's Opko Health position peaked at $1.08M in Q3 2024.
235 funds tracked by Wall St. Rank held Opko Health as of Q4 2024.

Based on Clearline Capital's 13F filing for Q4 2024, filed 14 Feb 2025.